Back to top
more

Heska Corporation (HSKA)

(Delayed Data from NSDQ)

$79.28 USD

79.28
71,295

+3.36 (4.43%)

Updated May 3, 2019 04:00 PM ET

After-Market: $79.10 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Heska (HSKA) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 9.38% and 3.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Heska (HSKA)

by Zacks Equity Research

Heska (HSKA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Heska (HSKA) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Heska (HSKA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Reata (RETA) Confirms Omaveloxolone NDA Filing in Q1 2022

by Zacks Equity Research

Reata (RETA) confirms submission of an NDA seeking approval for omaveloxolone to the FDA in the first quarter of 2022, following the completion of its pre-NDA meeting with the FDA.

Heska (HSKA) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 555.56% and 11.48%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Edwards Lifesciences (EW) in Q1 Earnings?

by Zacks Equity Research

Continued strength in the adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciences' (EW) Q1 revenues.

Heska (HSKA) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 166.67% and 16.66%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Heska (HSKA) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Heska (HSKA) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Heska (HSKA) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 44.00% and -8.40%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Heska (HSKA) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Heska (HSKA) Surpasses Q4 Earnings Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 133.33% and -1.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Heska (HSKA) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 25.00% and 2.61%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Heska (HSKA) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Neena Mishra headshot

An ETF to Capitalize on the Booming Pet Industry

by Neena Mishra

The pet industry is growing at about twice the rate of GDP; here is how investors can benefit from this trend.

Heska (HSKA) Surpasses Q3 Earnings Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 31.43% and -0.60%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Heska (HSKA) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Heska (HSKA) Tops Q2 Earnings Estimates

by Zacks Equity Research

Heska (HSKA) delivered earnings and revenue surprises of 41.18% and -1.74%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    New Strong Sell Stocks for July 9th

    by Zacks Equity Research

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

      Why Heska (HSKA) Might Surprise This Earnings Season

      by Zacks Equity Research

      Heska (HSKA) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.

        TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion

        by Zacks Equity Research

        TESARO's (TSRO) marketing application for approval of its PARP-inhbitor Zejula as monotherapy for the maintenance treatment of ovarian cancer gets positive CHMP opinion.

          Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR

          by Zacks Equity Research

          Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR

            Tirthankar Chakraborty headshot

            5 Efficient Stocks to Buy for a Healthy Portfolio

            by Tirthankar Chakraborty

            Companies with a favorable efficiency level is expected to provide impressive returns as it is believed to be positively correlated with its price performance

              Why Heska (HSKA) Could Be Positioned for a Surge

              by Zacks Equity Research

              Heska (HSKA) is seeing positive earnings estimate revisions suggesting that it could be a solid choice for investors.

                Tirthankar Chakraborty headshot

                5 Top Efficient Stocks to Boost Your Portfolio

                by Tirthankar Chakraborty

                A company with a favorable efficiency level is expected to provide impressive returns as it is positively correlated with the price performance.